Changing clinical presentation of multiple myeloma

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1975 • 3,051 citations

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1983 • 2,745 citations

Multiple myeloma; a review of 26 cases.

1957 • 682 citations

A Prospective Study of 651 Patients

1987 • 264 citations

Cancer Incidence and Mortality Trends in the United States: 1935–74

1978 • 251 citations

Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients

1984 • 175 citations

Prognostic factors and staging in multiple myeloma: a reappraisal.

1986 • 164 citations

Immunosuppression and infection in multiple myeloma.

1986 • 123 citations

Comparison of Trends in the Incidence of Multiple Myeloma in Malmö, Sweden, and Other Countries, 1950–1979

1984 • 84 citations

Increasing trends of multiple myeloma mortality in England and Wales; 1950-79: are the changes real?

1982 • 50 citations

International variations and temporal trends in mortality from multiple myeloma

1983 • 47 citations

Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma.

1990 • 29 citations

Plasma cell DNA content in multiple myeloma and related paraproteinemic disorders. Relationship with clinical and cytokinetic features

1984 • 15 citations

Rate of M-component changes and plasma cell labeling index in 25 patients with multiple myeloma treated with peptichemio.

1985 • 12 citations

Serum Thymidine Kinase and Beta-2 Microglobulin in Monoclonal Gammopathies

1987 • 11 citations